| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | 0.32 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |